Charles River Laboratories Announces First-Quarter 2015 Results from Continuing Operations

Go back to Charles River Laboratories Announces First-Quarter 2015 Results from Continuing Operations

Charles River Laboratorie (CRL) Misses Q1 EPS by 3c

April 29, 2015 4:36 PM EDT

Charles River Laboratorie (NYSE: CRL) reported Q1 EPS of $0.79, $0.03 worse than the analyst estimate of $0.82. Revenue for the quarter came in at $320.4 million versus the consensus estimate of $324 million.

Charles River Laboratorie sees FY2015 EPS of $3.55-$3.65, versus the consensus of $3.60.

For... More